These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 8184537)

  • 1. Function of human cytomegalovirus glycoprotein B: syncytium formation in cells constitutively expressing gB is blocked by virus-neutralizing antibodies.
    Tugizov S; Navarro D; Paz P; Wang Y; Qadri I; Pereira L
    Virology; 1994 Jun; 201(2):263-76. PubMed ID: 8184537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutated forms of human cytomegalovirus glycoprotein B are impaired in inducing syncytium formation.
    Tugizov S; Wang Y; Qadri I; Navarro D; Maidji E; Pereira L
    Virology; 1995 Jun; 209(2):580-91. PubMed ID: 7778290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycoprotein B of human cytomegalovirus promotes virion penetration into cells, transmission of infection from cell to cell, and fusion of infected cells.
    Navarro D; Paz P; Tugizov S; Topp K; La Vail J; Pereira L
    Virology; 1993 Nov; 197(1):143-58. PubMed ID: 7692667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humoral immune response to functional regions of human cytomegalovirus glycoprotein B.
    Navarro D; Lennette E; Tugizov S; Pereira L
    J Med Virol; 1997 Aug; 52(4):451-9. PubMed ID: 9260696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal Antibodies to Different Components of the Human Cytomegalovirus (HCMV) Pentamer gH/gL/pUL128L and Trimer gH/gL/gO as well as Antibodies Elicited during Primary HCMV Infection Prevent Epithelial Cell Syncytium Formation.
    Gerna G; Percivalle E; Perez L; Lanzavecchia A; Lilleri D
    J Virol; 2016 Jul; 90(14):6216-6223. PubMed ID: 27122579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigenic domain 1 is required for oligomerization of human cytomegalovirus glycoprotein B.
    Britt WJ; Jarvis MA; Drummond DD; Mach M
    J Virol; 2005 Apr; 79(7):4066-79. PubMed ID: 15767408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of association between the kinetics of human cytomegalovirus (HCMV) glycoprotein B (gB)-specific and neutralizing serum antibodies and development or recovery from HCMV active infection in patients undergoing allogeneic stem cell transplant.
    Muñoz I; Gutiérrez A; Gimeno C; Farga A; Alberola J; Solano C; Prósper F; García-Conde J; Navarro D
    J Med Virol; 2001 Sep; 65(1):77-84. PubMed ID: 11505447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell Fusion Induced by a Fusion-Active Form of Human Cytomegalovirus Glycoprotein B (gB) Is Inhibited by Antibodies Directed at Antigenic Domain 5 in the Ectodomain of gB.
    Reuter N; Kropff B; Schneiderbanger JK; Alt M; Krawczyk A; Sinzger C; Winkler TH; Britt WJ; Mach M; Thomas M
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32641474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cytoplasmic domain length on cell surface expression and syncytium-forming capacity of the simian immunodeficiency virus envelope glycoprotein.
    Spies CP; Compans RW
    Virology; 1994 Aug; 203(1):8-19. PubMed ID: 8030287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the contributions of the equine herpesvirus 1 glycoprotein gB homolog to virus entry and direct cell-to-cell spread.
    Neubauer A; Braun B; Brandmuller C; Kaaden OR; Osterrieder N
    Virology; 1997 Jan; 227(2):281-94. PubMed ID: 9018127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-function analysis of herpes simplex virus glycoprotein B with fusion-from-without activity.
    Roller DG; Dollery SJ; Doyle JL; Nicola AV
    Virology; 2008 Dec; 382(2):207-16. PubMed ID: 18950828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies specific for the antigenic domain 1 of glycoprotein B (gpUL55) of human cytomegalovirus bind to different substructures.
    Schoppel K; Hassfurther E; Britt W; Ohlin M; Borrebaeck CA; Mach M
    Virology; 1996 Feb; 216(1):133-45. PubMed ID: 8614980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural domains involved in human cytomegalovirus glycoprotein B-mediated cell-cell fusion.
    Bold S; Ohlin M; Garten W; Radsak K
    J Gen Virol; 1996 Sep; 77 ( Pt 9)():2297-302. PubMed ID: 8811030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Function of glycoprotein B homologues of the family herpesviridae.
    Pereira L
    Infect Agents Dis; 1994 Feb; 3(1):9-28. PubMed ID: 7952927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Location, location, timing: analysis of cytomegalovirus epitopes for neutralizing antibodies.
    Schrader JW; McLean GR
    Immunol Lett; 2007 Sep; 112(1):58-60. PubMed ID: 17714794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human cytomegalovirus glycoprotein B is required for virus entry and cell-to-cell spread but not for virion attachment, assembly, or egress.
    Isaacson MK; Compton T
    J Virol; 2009 Apr; 83(8):3891-903. PubMed ID: 19193805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of gpUL132, a structural component of human cytomegalovirus, results in impaired virus replication in fibroblasts.
    Spaderna S; Kropff B; Ködel Y; Shen S; Coley S; Lu S; Britt W; Mach M
    J Virol; 2005 Sep; 79(18):11837-47. PubMed ID: 16140760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Little role of anti-gB antibodies in neutralizing activity of patient's sera with human cytomegalovirus (HCMV) infection.
    Park JW; Kim DJ; Kim J; Park CG; Hwang ES; Cha CY
    J Korean Med Sci; 2000 Apr; 15(2):133-8. PubMed ID: 10803687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human herpesvirus 8 envelope-associated glycoprotein B interacts with heparan sulfate-like moieties.
    Akula SM; Pramod NP; Wang FZ; Chandran B
    Virology; 2001 Jun; 284(2):235-49. PubMed ID: 11384223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic T cell immunity to human cytomegalovirus glycoprotein B.
    Hopkins JI; Fiander AN; Evans AS; Delchambre M; Gheysen D; Borysiewicz LK
    J Med Virol; 1996 Jun; 49(2):124-31. PubMed ID: 8991935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.